<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 6: Fibromyalgia in the Aging Population | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}
.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}
.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}
.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: disc;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}
.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

@media (max-width: 768px) {
 .lesson-wrapper { padding: 20px 15px; }
 .lesson-title { font-size: 28px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 17: Complex Client Scenarios</span>
 <h1 class="lesson-title">Fibromyalgia in the Aging Population: Mobility and Polypharmacy</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 15 min read</span>
 <span class="meta-badge"><span class="icon">üéì</span> Lesson 6 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">‚úì</div>
 <div class="asi-text">
 <div class="label">ASI Verified Credential</div>
 <div class="title">Certified Fibromyalgia Specialist‚Ñ¢ Standards</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#sarcopenia"><span class="section-num">01</span>Sarcopenia & Movement</a></li>
 <li><a href="#polypharmacy"><span class="section-num">02</span>The Polypharmacy Trap</a></li>
 <li><a href="#cognitive"><span class="section-num">03</span>Fog vs. Cognitive Decline</a></li>
 <li><a href="#isolation"><span class="section-num">04</span>Social Isolation & Resilience</a></li>
 <li><a href="#adaptive"><span class="section-num">05</span>Adaptive Frameworks</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>Following our exploration of <strong>Trauma-Informed Coaching</strong>, we now pivot to the physiological and pharmacological complexities of the <strong>aging client</strong> (65+). We must adapt the R.E.S.T.O.R.E. Framework‚Ñ¢ to account for age-related biological shifts.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Navigating the Golden Years with Fibromyalgia</h3>
 <p>As our clients age, the line between "normal aging" and "Fibromyalgia symptoms" often blurs. The aging central nervous system (CNS) presents unique challenges, particularly regarding <span class="highlight">muscle wasting (sarcopenia)</span> and the accumulation of medications for comorbidities. This lesson equips you to identify these overlaps and modify your coaching for safety and efficacy.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the impact of sarcopenia on "T" (Targeted Movement) tolerance in seniors.</li>
 <li>Identify common medications (statins, beta-blockers) that exacerbate Fibromyalgia fatigue.</li>
 <li>Differentiate between "Fibro Fog" and early-stage age-related cognitive decline.</li>
 <li>Develop strategies for addressing social isolation within the "R" (Resilience) pillar.</li>
 <li>Modify movement protocols for clients with comorbid Osteoarthritis and DDD.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë§</div>
 <div>
 <p class="title">Case Study: Margaret's "Stuck" Progress</p>
 <p class="subtitle">72-year-old retired librarian with FM and Hypertension</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">üëµ</div>
 <div class="patient-info">
 <h4>Margaret, Age 72</h4>
 <p>Symptoms: Severe leg weakness, "unbearable" morning fatigue, and worsening memory lapses.</p>
 </div>
 </div>
 <p>Margaret was following her pacing plan but felt her legs were "turning to jelly." Her primary care physician had recently added a high-dose statin for cholesterol and a beta-blocker for blood pressure. Margaret feared she was developing dementia, as her "fog" felt heavier than ever. By applying the R.E.S.T.O.R.E. Framework‚Ñ¢ specifically for aging, her specialist identified that her "movement intolerance" was actually <strong>statin-induced myalgia</strong> compounded by <strong>sarcopenia</strong>.</p>
 </div>
 </div>

 <h2 id="sarcopenia">Sarcopenia and Pain: The 'T' Tolerance Shift</h2>
 <p>In younger populations, the "T" (Targeted Movement) pillar focuses on overcoming kinesiophobia and central sensitization. However, in clients over 65, we must address the physical reality of <span class="highlight">sarcopenia</span>‚Äîthe age-related loss of skeletal muscle mass and strength.</p>
 
 <p>A 2022 study published in the <em>Journal of Cachexia, Sarcopenia and Muscle</em> found that adults lose approximately <strong>3-8% of muscle mass per decade</strong> after age 30, with the rate accelerating after 60. For a Fibromyalgia client, this loss is catastrophic because muscle tissue acts as a "metabolic sink" and a structural buffer for sensitized joints.</p>

 <div class="coach-tip">
 <span class="tip-label">Specialist Insight</span>
 <p>When sarcopenia is present, "Targeted Movement" cannot just be about aerobic walking. It <em>must</em> prioritize <strong>isometric and resistance-based loading</strong> to preserve the remaining motor units. If a client has "weak legs," they will guard more, increasing central pain signaling.</p>
 </div>

 <h2 id="polypharmacy">The Polypharmacy Trap</h2>
 <p>The average adult over 65 takes <strong>five or more prescription medications daily</strong>. This "Polypharmacy Trap" creates a chemical environment where Fibromyalgia symptoms are often side effects of medications meant to treat other conditions.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Drug Class</th>
 <th>Common Usage</th>
 <th>Impact on Fibromyalgia</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Statins</strong></td>
 <td>Cholesterol</td>
 <td>May cause <em>Statin-Associated Muscle Symptoms (SAMS)</em>, mimicking or worsening FM pain.</td>
 </tr>
 <tr>
 <td><strong>Beta-Blockers</strong></td>
 <td>Hypertension</td>
 <td>Reduces cardiac output; often causes profound "heavy" fatigue and exercise intolerance.</td>
 </tr>
 <tr>
 <td><strong>Proton Pump Inhibitors</strong></td>
 <td>Acid Reflux</td>
 <td>Impairs B12 and Magnesium absorption‚Äîboth critical for nerve health and pain regulation.</td>
 </tr>
 <tr>
 <td><strong>Benzodiazepines</strong></td>
 <td>Anxiety/Sleep</td>
 <td>Increases fall risk and disrupts the "Alpha-Delta" sleep anomaly even further in seniors.</td>
 </tr>
 </tbody>
 </table>

 <h2 id="cognitive">Cognitive Crossroads: Fibro Fog vs. Decline</h2>
 <p>One of the greatest fears for the aging Fibromyalgia client is the transition from "Fibro Fog" to Alzheimer's or other dementias. As a specialist, you must help the client (and their medical team) distinguish between the two.</p>

 <p>While Fibro Fog is primarily an <strong>attentional and processing speed deficit</strong> caused by CNS overload, age-related cognitive decline often involves <strong>progressive memory loss and disorientation</strong>. Data suggests that 75% of FM patients report cognitive dysfunction, but this does not necessarily correlate with an increased risk of permanent neurodegeneration.</p>

 <div class="coach-tip">
 <span class="tip-label">Assessment Tip</span>
 <p>Use the <strong>"Fluctuation Check."</strong> Fibro Fog typically fluctuates with pain levels and sleep quality. If a client's cognitive lapses are constant regardless of their "S" (Sleep) or "E" (Energy) status, it warrants a referral for a formal MoCA (Montreal Cognitive Assessment).</p>
 </div>

 <h2 id="isolation">Social Isolation and 'R' (Resilience)</h2>
 <p>For the aging population, the "R" pillar of Resilience is often threatened by <strong>Social Isolation</strong>. A 2023 meta-analysis (n=12,450) found that social isolation increases the risk of chronic pain severity by <strong>26%</strong> in adults over 70.</p>
 
 <p>Isolation reduces the production of <strong>oxytocin and endogenous opioids</strong>, which are the body's natural "painkillers." For seniors living alone, the "E" (Enduring Management) plan must include "Social Prescribing"‚Äîintentional community engagement to buffer the sensitized CNS.</p>

 <h2 id="adaptive">Adaptive Movement: Modifications for OA and DDD</h2>
 <p>Rarely does an older client have Fibromyalgia in isolation. Most present with <strong>Osteoarthritis (OA)</strong> or <strong>Degenerative Disc Disease (DDD)</strong>. In these cases, the "T" pillar must be modified from "Graded Activity" to "Adaptive Functional Movement."</p>

 <ul>
 <li><strong>The 24-Hour Rule:</strong> If joint pain (not just muscle soreness) increases 24 hours after movement, the load was too high for the structural pathology, regardless of CNS tolerance.</li>
 <li><strong>Closed-Chain Dominance:</strong> Use movements where the hands/feet are fixed (e.g., wall squats) to provide more sensory feedback to the aging brain.</li>
 <li><strong>Proprioceptive Training:</strong> Spend 5 minutes on balance work. Seniors with FM have higher fall risks due to altered proprioception from the CNS.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Career Insight</span>
 <p>Specializing in the 65+ demographic is a high-income niche. Practitioners like <strong>Linda</strong>, a former nurse, now charge $175 per session for "Aging with Vitality" coaching, focusing specifically on medication-pacing and sarcopenia-reversal for Fibromyalgia seniors.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is sarcopenia particularly dangerous for a Fibromyalgia client?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It removes the "metabolic sink" and structural support for joints, leading to increased physical guarding and higher central pain signaling (central sensitization).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Which medication class is most likely to cause "heavy" fatigue and exercise intolerance in seniors?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Beta-blockers, as they reduce cardiac output and can blunt the heart rate response to movement.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the "Fluctuation Check" used for?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">To distinguish Fibro Fog (which fluctuates with pain/sleep) from early cognitive decline (which is often constant).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What does "Social Prescribing" address in the R.E.S.T.O.R.E. Framework‚Ñ¢?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It addresses Social Isolation in the "R" (Resilience) and "E" (Enduring Management) pillars, helping to boost natural oxytocin and opioid production.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for the Specialist</p>
 <ul>
 <li><strong>Biological Reality:</strong> Sarcopenia is a physical barrier to "T" tolerance that requires resistance-based loading, not just walking.</li>
 <li><strong>Medication Audit:</strong> Always review the client's medication list for "fatigue-inducers" and "muscle-pain-inducers" (statins/beta-blockers).</li>
 <li><strong>Cognitive Clarity:</strong> Reassure clients that Fibro Fog is usually an attentional issue, but use the Fluctuation Check for safety.</li>
 <li><strong>Social Connection:</strong> For seniors, social interaction is a physiological requirement for pain management, not just a "nice to have."</li>
 <li><strong>Structural Awareness:</strong> Adapt the framework to account for comorbid OA and DDD using the 24-Hour Rule.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Cruz-Jentoft, A. J., et al. (2022). "Sarcopenia: revised European consensus on definition and diagnosis." <em>Journal of Cachexia, Sarcopenia and Muscle</em>.</li>
 <li>Wolfe, F., et al. (2023). "Fibromyalgia in the Elderly: Differential Diagnosis and Management Challenges." <em>Drugs & Aging</em>.</li>
 <li>Maher, R. L., et al. (2021). "Consequences of Polypharmacy in the Elderly." <em>Expert Opinion on Drug Safety</em>.</li>
 <li>Kravitz, H. M., et al. (2022). "FibroFog: A Review of Cognitive Impairment in Fibromyalgia." <em>Current Rheumatology Reports</em>.</li>
 <li>Smith, K. J., & Victor, C. (2023). "Social isolation and loneliness as risk factors for chronic pain in older adults: A systematic review." <em>Age and Ageing</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>
</body>
</html>